Fakultní nemocnice Plzeň has announced a world first in oncological diagnostics. Doctors are now combining the radiopharmaceutical 68Ga-Trivehexin with PET/MRI scans, which merge positron emission tomography and magnetic resonance imaging. This novel approach allows for a more precise visualization of tumors and accurate differentiation from surrounding inflammatory tissue. The combination offers improved accuracy in diagnosing pancreatic cancer. This advancement represents a significant step forward in the early and effective management of this challenging disease. The hospital’s achievement positions Plzeň as a leader in advanced cancer diagnostic techniques. It promises to benefit patients through quicker, more accurate diagnoses and potentially improved treatment outcomes.